150 related articles for article (PubMed ID: 15994740)
1. Glucocorticoids and outcome of radioactive iodine therapy for Graves' hyperthyroidism.
Bartalena L; Tanda ML; Piantanida E; Lai A
Eur J Endocrinol; 2005 Jul; 153(1):13-4. PubMed ID: 15994740
[No Abstract] [Full Text] [Related]
2. Glucocorticoid therapy of Graves' ophthalmopathy.
Bartalena L; Marocci C; Bogazzi F; Bruno-Bossio G; Pinchera A
Exp Clin Endocrinol; 1991 May; 97(2-3):320-7. PubMed ID: 1915650
[No Abstract] [Full Text] [Related]
3. Do glucocorticoids affect outcome in Graves' disease following radioiodine therapy?
Salvatore D; Fenzi G
Nat Clin Pract Endocrinol Metab; 2006 Apr; 2(4):194-5. PubMed ID: 16932282
[No Abstract] [Full Text] [Related]
4. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy.
Bartalena L; Marcocci C; Bogazzi F; Manetti L; Tanda ML; Dell'Unto E; Bruno-Bossio G; Nardi M; Bartolomei MP; Lepri A; Rossi G; Martino E; Pinchera A
N Engl J Med; 1998 Jan; 338(2):73-8. PubMed ID: 9420337
[TBL] [Abstract][Full Text] [Related]
5. [Influence of glucocorticoid therapy on intratherapeutic biodistribution of 131I radioiodine therapy in Graves' disease].
Halstenberg J; Kranert WT; Korkusuz H; Mayer A; Ackermann H; Grünwald F; Happel C
Nuklearmedizin; 2018 Apr; 57(2):43-49. PubMed ID: 29590674
[TBL] [Abstract][Full Text] [Related]
6. Glucocorticoids do not influence the effect of radioiodine therapy in Graves' disease.
Jensen BE; Bonnema SJ; Hegedüs L
Eur J Endocrinol; 2005 Jul; 153(1):15-21. PubMed ID: 15994741
[TBL] [Abstract][Full Text] [Related]
7. Oral steroid prophylaxis for Graves' orbitopathy after radioactive iodine treatment for Graves' disease is not only effective, but also safe.
Rosetti S; Tanda ML; Veronesi G; Masiello E; Premoli P; Gallo D; Cusini C; Donati S; Sabatino J; Ippolito S; Piantanida E; Bartalena L
J Endocrinol Invest; 2020 Mar; 43(3):381-383. PubMed ID: 31587179
[No Abstract] [Full Text] [Related]
8. Preventing Graves' ophthalmopathy.
Wiersinga WM
N Engl J Med; 1998 Jan; 338(2):121-2. PubMed ID: 9420345
[No Abstract] [Full Text] [Related]
9. Impact of lithium on efficacy of radioactive iodine therapy for Graves' disease: a cohort study on cure rate, time to cure, and frequency of increased serum thyroxine after antithyroid drug withdrawal.
Bogazzi F; Giovannetti C; Fessehatsion R; Tanda ML; Campomori A; Compri E; Rossi G; Ceccarelli C; Vitti P; Pinchera A; Bartalena L; Martino E
J Clin Endocrinol Metab; 2010 Jan; 95(1):201-8. PubMed ID: 19906789
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study.
Marcocci C; Bartalena L; Tanda ML; Manetti L; Dell'Unto E; Rocchi R; Barbesino G; Mazzi B; Bartolomei MP; Lepri P; Cartei F; Nardi M; Pinchera A
J Clin Endocrinol Metab; 2001 Aug; 86(8):3562-7. PubMed ID: 11502779
[TBL] [Abstract][Full Text] [Related]
11. Radioactive iodine therapy in Graves' hyperthyroidism: a prospective study from a tertiary referral centre in north India.
Sankar R; Sekhri T; Sripathy G; Walia RP; Jain SK
J Assoc Physicians India; 2005 Jul; 53():603-6. PubMed ID: 16190128
[TBL] [Abstract][Full Text] [Related]
12. [Radioactive iodine (I-131) therapy].
Kusakabe K; Maki M
Nihon Rinsho; 1999 Aug; 57(8):1855-8. PubMed ID: 10483265
[TBL] [Abstract][Full Text] [Related]
13. Radioiodine therapy for Graves' disease: case selection and restrictions recommended to patients in North America.
Wartofsky L
Thyroid; 1997 Apr; 7(2):213-6. PubMed ID: 9133687
[TBL] [Abstract][Full Text] [Related]
14. Relapse of Graves' disease 23 years after treatment with radioactive iodine (131I).
Hegele RA; Volpé R
J Clin Lab Immunol; 1985 Oct; 18(2):103-5. PubMed ID: 3841162
[TBL] [Abstract][Full Text] [Related]
15. An optimal treatment for pediatric Graves' disease is radioiodine.
Rivkees SA; Dinauer C
J Clin Endocrinol Metab; 2007 Mar; 92(3):797-800. PubMed ID: 17341574
[TBL] [Abstract][Full Text] [Related]
16. Treatment with propylthiouracil before radioactive iodine therapy is associated with a higher treatment failure rate than therapy with radioactive iodine alone in Graves' disease.
Tuttle RM; Patience T; Budd S
Thyroid; 1995 Aug; 5(4):243-7. PubMed ID: 7488862
[TBL] [Abstract][Full Text] [Related]
17. Ablative or non-ablative therapy for Graves' hyperthyroidism in patients with ophthalmopathy?
Marcocci C; Bartalena L; Pinchera A
J Endocrinol Invest; 1998; 21(7):468-71. PubMed ID: 9766264
[No Abstract] [Full Text] [Related]
18. [Treatment of hyperthyroidism and indications for radioactive iodine].
Huysmans DA; Hermus AR; Smals AG; Corstens FH; Kloppenborg PW
Ned Tijdschr Geneeskd; 1995 Jun; 139(24):1251-2. PubMed ID: 7791938
[No Abstract] [Full Text] [Related]
19. Qualitative and quantitative impact of protective glucocorticoid therapy on the effective 131I half-life in radioiodine therapy for Graves disease.
Hautzel H; Pisar E; Yazdan-Doust N; Schott M; Beu M; Müller HW
J Nucl Med; 2010 Dec; 51(12):1917-22. PubMed ID: 21078788
[TBL] [Abstract][Full Text] [Related]
20. The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves' hyperthyroidism: one-year follow-up of a prospective, randomized study.
Andrade VA; Gross JL; Maia AL
J Clin Endocrinol Metab; 2001 Aug; 86(8):3488-93. PubMed ID: 11502768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
